Clinical Trial Update: Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

This early phase 1 trial evaluates nivolumab in combination with chemotherapy before surgery in patients with borderline resectable pancreatic cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Cancer
• Resectable Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: COMPLETED